Johnson M L, Keeton L G, Zhu Z B, Volanakis J E, Cooper M D, Schroeder H W
Department of Medicine, University of Alabama at Birmingham, 35294-3300, USA.
Clin Exp Immunol. 1997 Jun;108(3):477-83. doi: 10.1046/j.1365-2249.1997.3801278.x.
The concentration of serum immunoglobulins in individuals with IgA deficiency (IgAD) and CVID can vary with age to have practical implications for evaluation, therapy, and genetic analysis. Most IgAD and CVID patients in our clinic population in the Southeastern United States have inherited part or all of two extended MHC haplotypes, referred to as haplotype 1 (HLA-DQB1 0201, HLA-DR3, C4B-Sf, C4A-0, G1-15, Bf-0.4, C2-a, HSP-7.5, TNF alpha-5, HLA-B8, HLA-A1) and haplotype 2 (HLA-DQB1 0201, HLA-DR-7, C4B-S, C4A-L, G11-4.5, Bf-0.6, C2-b, HSP-9, TNF alpha-9, HLA-B44, HLA-A29). In the present study, the clinic records of 68 CVID patients and 73 IgAD patients were reviewed to determine whether patients with familial or MHC-associated IgAD or CVID experience changes in serum immunoglobulin concentrations. An increase in serum immunoglobulin to the normal range was associated with clinical improvement in one patient with CVID and haplotype 2, two patients with IgAD and haplotype 2, and one IgAD patient whose haplotype was not determined. Two patients with haplotype 1 and one with haplotype 2 had a significant decline in serum immunoglobulin: one progressed from normal to IgAD associated with IgG subclass deficiencies, and two progressed from IgAD to CVID. Five of the seven patients with notable changing serum immunoglobulin levels have a family member with either IgAD or CVID. The findings suggest that familial, MHC-associated IgAD and CVID may be either progressive or reversible disorders, and emphasize the value of monitoring immunoglobulin levels in affected individuals and their family members.
患有IgA缺乏症(IgAD)和常见变异型免疫缺陷病(CVID)的个体血清免疫球蛋白浓度会随年龄变化,这对评估、治疗和基因分析具有实际意义。在美国东南部我们诊所的大多数IgAD和CVID患者都遗传了两个扩展的MHC单倍型的部分或全部,分别称为单倍型1(HLA - DQB1 0201、HLA - DR3、C4B - Sf、C4A - 0、G1 - 15、Bf - 0.4、C2 - a、HSP - 7.5、TNFα - 5、HLA - B8、HLA - A1)和单倍型2(HLA - DQB1 0201、HLA - DR - 7、C4B - S、C4A - L、G11 - 4.5、Bf - 0.6、C2 - b、HSP - 9、TNFα - 9、HLA - B44、HLA - A29)。在本研究中,回顾了68例CVID患者和73例IgAD患者的临床记录,以确定患有家族性或MHC相关IgAD或CVID的患者血清免疫球蛋白浓度是否发生变化。一名患有CVID和单倍型2的患者、两名患有IgAD和单倍型2的患者以及一名单倍型未确定的IgAD患者,其血清免疫球蛋白增加至正常范围与临床改善相关。两名具有单倍型1的患者和一名具有单倍型2的患者血清免疫球蛋白显著下降:一名从正常进展为伴有IgG亚类缺陷的IgAD,两名从IgAD进展为CVID。血清免疫球蛋白水平有显著变化的7名患者中有5名有家庭成员患有IgAD或CVID。这些发现表明,家族性、MHC相关的IgAD和CVID可能是进行性或可逆性疾病,并强调了监测受影响个体及其家庭成员免疫球蛋白水平的价值。